• Corpus ID: 57227785

Evaluation du traitement antirétroviral chez l'adulte infecté par le VIH au Service de Dermatologie Vénérologie de l'Hôpital National Donka

@inproceedings{Cisse2012EvaluationDT,
  title={Evaluation du traitement antir{\'e}troviral chez l'adulte infect{\'e} par le VIH au Service de Dermatologie V{\'e}n{\'e}rologie de l'H{\^o}pital National Donka},
  author={Mohamed Cissé and F. B. Sako and B. Diaby and Mohamed Macir{\'e} Soumah and Thierno Tounkara and Boh Fanta Dian{\'e} and H. Bald{\'e} and Ad Camara and Ad Camara},
  year={2012}
}
If the use of the highly active antiretroviral therapies (HAART) have largely improved survival, morbidity and the quality of life of the people living with HIV in Northern countries as well as Southern countries and particularly in Africa, many obstacles have slowed down their use. Thus the follow-up of the patients under HAART in certain developing countries is still timid even non-existent. Objective : The objective of this work was to bring the therapeutic outcomes obtained after a minimal… 
malimedical.org
4 Citations
Highly Influential Citations
3
Background Citations
2
Results Citations
2

Figures from this paper

4 Citations

[Evolution of biochemical and hematological parameters in patients living with HIV/AIDS treated with antiretroviral therapy at the Aboubacar Sangoulé Lamizana General Camp Medical Center].

The increase in the rate of TCD4 lymphocytes and in the rates of hemoglobin levels gives an indication of ART effectiveness and of patient's tolerance to treatment.

Effects of the Therapeutic Diagrams on the Biological Parameters of the Patients under Antiretroviral Treatment during the Monitoringin Integrated Centre for Bioclinical Research of Abidjan (Cote d'Ivoire)

This study shows that the different therapeutic classes had an effect on the biological parameters of subjects infected by HIV, and the 2NRTIs+1NNRTI therapeutic class was the most used during treatment.

Prevalence of therapeutic failure and evolution of biological factors amongst people living with HIV enrolled in antiretroviral therapy at the Ambulatory Treatment Center in Nouakchott, Mauritania

The prevalence of therapeutic failure and the evolution of the biological factors after 6 and 12 months of anti‐retroviral treatment (ART) amongst human immunodefeciency virus (HIV) patients receiving care through the Ambulatory Treatment Center in Nouakchott is determined.

Evolution des paramètres biochimiques et hématologiques chez les personnes vivant avec le VIH/SIDA sous traitement antirétroviral au Centre Médical du Camp General Aboubacar Sangoule Lamizana

Introduction l'objectif de ce travail était d'évaluer l'impact du traitement sur les paramètres biochimiques et hématologiques des patients VIH positifs suivis au Centre Médical du Camp Général…

10 References

Late presenters in the era of highly active antiretroviral therapy: uptake of and responses to antiretroviral therapy

Those presenting for care with very low CD4 cell counts may make large demands on clinical resources, particularly over the first few months, while some patients do have a poor outcome on highly active antiretroviral therapy.

Late diagnosis of HIV infection in the era of highly active antiretroviral therapy: consequences for AIDS incidence

A growing proportion of AIDS cases involves late diagnosis of HIV infection and Persons who are unaware of their HIV infection cannot benefit from antiretroviral therapy and, hence, early diagnosis would strengthen the impact of such therapy and so reduce AIDS incidence.

Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial.

No time to wait: how many HIV-infected homosexual men are diagnosed late and consequently die? (England and Wales, 1993–2002)

The continued late diagnosis of one in four MSM means these individuals lose the option to start therapy early, miss opportunities to prevent further transmission and are approximately 10 times more likely to die within a year of diagnosis.

Efficacité et tolérance du traitement antirétroviral dans le contexte de l'Initiative sénégaliase d'accès aux antirétroviraux

L'utilisation des multithérapies antirétrovirales (ARV) a grandement amélioré la survie, la morbidité et la qualité de vie des PvVIH dans les pays du Nord [3, 6, 15]. Dans les pays du Sud, et…

Late presentation of HIV infection associated with prolonged survival following AIDS diagnosis—characteristics of individuals

Late presenters survived longer following AIDS diagnosis (P <0.0001), which may indicate a positive response by drug naïve patients to antiretroviral therapies followingAIDS diagnosis.

Incidence

The limited amount of data and the many subgroups formed, the occupational Genesis of the cancer ex cess should not be overinterpreted.

L'initiative sénégalaise d'accès aux médicaments antirétroviraux : analyses économiques, sociales, comportementales et médicales

Evaluation du traitement antirétroviral chez les adultes infecté par le VIH , suivis dans le service d ’ Hématologie du CHU de Brazzaville , Congo

  • Bull Soc Pathol Exot
  • 2008

Épidémiologie de la prise en charge tardive : Journée de réflexion scientifique

  • L ’ initiative sénégalaise d ’ accès aux médicaments antirétroviraux
  • 2002